T1	PROC 48 78	Ensayo clínico abierto, fase I
T6	Dose 158 173	dosis repetidas
T8	LIVB 212 217	niños
#1	AnnotatorNotes T8	C0008059; Child; Age Group | C0870221; Boys; Age Group
T9	Age 212 217	niños
T10	LIVB 220 232	adolescentes
#2	AnnotatorNotes T10	C0205653; Adolescent (age group); Age Group
T11	Age 220 232	adolescentes
T13	DISO 284 293	Epilepsia
#3	AnnotatorNotes T13	C0014544; Epilepsy; Disease or Syndrome
T15	DISO 363 387	encefalitis de Rasmussen
#4	AnnotatorNotes T15	C0393484; Rasmussen Syndrome; Disease or Syndrome
T16	PROC 432 456	consentimiento informado
#5	AnnotatorNotes T16	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T17	LIVB 461 481	Población pediátrica
T18	Age 482 498	menor de 16 años
T20	PROC 574 585	tratamiento
#6	AnnotatorNotes T20	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T21	CHEM 587 611	fármacos antiepilépticos
T22	PROC 614 638	terapia inmunomoduladora
T23	DISO 679 708	deterioro motor y/o cognitivo
T24	PROC 766 786	cirugía de epilepsia
T25	DISO 809 833	Encefalitis de Rasmussen
#7	AnnotatorNotes T25	C0393484; Rasmussen Syndrome; Disease or Syndrome
T26	PROC 868 871	RMC
#8	AnnotatorNotes T26	C0412692; Magnetic Resonance Imaging (MRI) of Heart; Diagnostic Procedure | C4028269; Nuclear magnetic resonance imaging brain; Diagnostic Procedure
T27	PROC 873 900	pruebas electrofisiológicas
T28	PROC 902 905	PET
#9	AnnotatorNotes T28	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T29	PROC 908 938	evaluaciones neuropsicológicas
T31	Spec_cue 1000 1006	pueden
T32	Speculated 1007 1014	afectar
T33	LIVB 1032 1040	paciente
#10	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	DISO 1064 1104	Infecciones activas del SNC o sistémicas
T35	DISO 1115 1120	Tumor
#11	AnnotatorNotes T35	C0027651; Neoplasms; Neoplastic Process | C0038999; Swelling; Finding
T36	PROC 1130 1143	Quimioterapia
#12	AnnotatorNotes T36	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure | C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T37	DISO 1153 1172	Enfermedad cardíaca
#13	AnnotatorNotes T37	C0018799; Heart Diseases; Disease or Syndrome
T38	DISO 1175 1183	Demencia
#14	AnnotatorNotes T38	C0497327; Dementia; Mental or Behavioral Dysfunction
T39	DISO 1191 1222	enfermedad degenerativa del SNC
T40	PROC 1259 1291	cateterismo del sistema arterial
T41	Contraindicated 1259 1291	cateterismo del sistema arterial
T42	Neg_cue 1314 1316	no
T43	Negated 1321 1329	factible
T44	DISO 1343 1371	trastornos de comportamiento
#15	AnnotatorNotes T44	C0004930; Behavior Disorders; Mental or Behavioral Dysfunction
T45	Neg_cue 1376 1383	impiden
T46	Negated 1388 1400	colaboración
T49	PROC 1437 1462	parámetros de coagulación
T50	Neg_cue 1529 1531	no
T53	DISO 1602 1621	reacciones adversas
#17	AnnotatorNotes T53	C0559546; Adverse reactions; Pathologic Function
T54	DISO 1624 1654	complicaciones tromboembólicas
T55	CHEM 1671 1695	componentes de la sangre
T56	PHYS 1701 1709	Embarazo
#18	AnnotatorNotes T56	C0032961; Pregnancy; Organism Function
T57	PHYS 1723 1732	lactancia
#19	AnnotatorNotes T57	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T58	Neg_cue 1737 1745	Negativa
T59	LIVB 1750 1758	paciente
#20	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	LIVB 1761 1771	familiares
#21	AnnotatorNotes T60	C0080103; Relative (related person); Family Group
T61	PROC 1777 1788	seguimiento
#22	AnnotatorNotes T61	C0420316; Other follow-up; Health Care Activity
T62	Negated 1777 1788	seguimiento
T63	PROC 1419 1434	acceso arterial
T47	Speculated 1419 1434	acceso arterial
T48	Speculated 1437 1462	parámetros de coagulación
T3	Route 140 154	intra-arterial
T5	CHEM 177 208	células mesenquimales autólogas
T2	PROC 1542 1576	administrar productos terapéuticos
T64	Negated 1542 1576	administrar productos terapéuticos
T19	DISO 969 981	Enfermedades
T30	Age 471 481	pediátrica
T52	DISO 318 327	Epilepsia
T14	DISO 237 247	epilepsias
T12	DISO 503 512	Epilepsia
T51	PROC 84 124	evaluar la seguridad y respuesta clínica
T7	LIVB 713 718	grupo
T4	PROC 131 154	infusión intra-arterial
